Cargando…

When the Price Is Right: Beyond the Medical Risks and Benefits of Costly Therapies

Detalles Bibliográficos
Autor principal:	Kittleson, Michelle M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238634/ https://www.ncbi.nlm.nih.gov/pubmed/35723004 http://dx.doi.org/10.1161/JAHA.122.026471

Ejemplares similares

Pricing Externalities to Balance Public Risks and Benefits of Research
por: Farquhar, Sebastian, et al.
Publicado: (2017)

Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China
por: Zhang, Yichen, et al.
Publicado: (2022)

Pricing Done Right
por: Smith, Tim
Publicado: (2016)

Pricing Treatments Cost-Effectively when They Have Multiple Indications: Not Just a Simple Threshold Analysis
por: Goldhaber-Fiebert, Jeremy D., et al.
Publicado: (2023)

Patient Use of Cost and Quality Data When Choosing a Joint Replacement Provider in the Context of Reference Pricing
por: Kandrack, Ryan, et al.
Publicado: (2015)

Pharmacy Benefit Manager Pricing and Spread Pricing for High-Utilization Generic Drugs
por: Mattingly, T. Joseph, et al.
Publicado: (2023)

Pricing and Cost Accounting
por: Oyer, Darrell
Publicado: (2011)

Cost-Based Pricing
por: Oyer, Darrell
Publicado: (2012)

Cost-Benefit Analysis of the LHC to 2025 and beyond: Was it Worth it ?
por: Prof. Florio, Massimo
Publicado: (2015)

Benefit assessment in Germany: implications for price discounts
por: Theidel, Ulrike, et al.
Publicado: (2016)

The boomerang effect of zero pricing: when and why a zero price is less effective than a low price for enhancing consumer demand
por: Fan, Xiaomeng, et al.
Publicado: (2022)

When Customers Help Set Prices
por: Mak, Vincent
Publicado: (2014)

Price Elasticity and Medication Use: Cost Sharing Across Multiple Clinical Conditions
por: Gatwood, Justin, et al.
Publicado: (2014)

Self care interventions for sexual and reproductive health and rights: costs, benefits, and financing
por: Remme, Michelle, et al.
Publicado: (2019)

The wisdom of the crowd playing The Price Is Right
por: Lee, Michael D., et al.
Publicado: (2010)

The Economics of Viagra Revisited: The Price Is Right
por: Agochukwu-Mmonu, Nnenaya, et al.
Publicado: (2021)

Cost-Benefit Analysis of the Large Hadron Collider to 2025 and beyond
por: Florio, Massimo, et al.
Publicado: (2015)

Heart Transplantation for Adriamycin Cardiomyopathy: The Plural of Anecdote and the Power of Registries
por: Kittleson, Michelle M.
Publicado: (2021)

Is there a “price that’s right” for at-home COVID tests?
por: Kirby, Rebecca Portney, et al.
Publicado: (2023)

Evaluating cost benefits of combination therapies for advanced melanoma
por: Jensen, Ivar S., et al.
Publicado: (2016)

A study on the response of carbon emission rights price to energy price macroeconomy and weather conditions
por: Shi, Changfeng, et al.
Publicado: (2022)

Outcome Probability versus Magnitude: When Waiting Benefits One at the Cost of the Other
por: Young, Michael E., et al.
Publicado: (2014)

Price of a hepatitis C cure: Cost of production and current prices for direct-acting antivirals in 50 countries
por: Barber, Melissa J., et al.
Publicado: (2020)

When are breakthrough therapies cost-effective?
por: Olchanski, Natalia, et al.
Publicado: (2022)

Who benefits from implantable cardioverter defibrillator therapy, and who pays the price?
por: Olde Nordkamp, L. R. A., et al.
Publicado: (2013)

Congenital Chagas Disease in the United States: The Effect of Commercially Priced Benznidazole on Costs and Benefits of Maternal Screening
por: Perez-Zetune, Victoria, et al.
Publicado: (2020)

The correlation between the costs and clinical benefits of national price-negotiated anticancer drugs for specific cancers in China
por: Bao, Yuwen, et al.
Publicado: (2023)

Generic cardiology drug prices: the potential benefits of the Marc Cuban cost plus drug company model
por: Narendrula, Aparna, et al.
Publicado: (2023)

Lot-sizing and pricing decisions for perishable products under three-echelon supply chains when demand depends on price and stock-age
por: Li, Ruihai, et al.
Publicado: (2021)

The impact of reference pricing and extension of generic substitution on the daily cost of antipsychotic medication in Finland
por: Koskinen, Hanna, et al.
Publicado: (2014)

Increases in Anti-infective Drug Prices, Subsequent Prescribing, and Outpatient Costs
por: Lee, Junsoo, et al.
Publicado: (2021)

Costs of locomotion in polar bears: when do the costs outweigh the benefits of chasing down terrestrial prey?
por: Gormezano, Linda J., et al.
Publicado: (2016)

Risk–benefit and cost–benefit ratio in headache treatment
por: Pini, L. A., et al.
Publicado: (2005)

Market Confidence Predicts Stock Price: Beyond Supply and Demand
por: Sun, Xiao-Qian, et al.
Publicado: (2016)

Price of pain: population-based cohort burden of disease analysis of medication cost of herpes zoster and postherpetic neuralgia
por: Friesen, Kevin J, et al.
Publicado: (2016)

Medical Tourism: A Cost or Benefit to the NHS?
por: Hanefeld, Johanna, et al.
Publicado: (2013)

The Cost Bubble in Medical Education: Will it Burst and When?
por: Walsh, K
Publicado: (2016)

Comparison of United States and Canadian Glaucoma Medication Costs and Price Change from 2006 to 2013
por: Schlenker, Matthew B., et al.
Publicado: (2015)

Cost-effectiveness and Pricing of Antibacterial Drugs
por: Verhoef, Talitha I, et al.
Publicado: (2015)

Potential benefits of minimum unit pricing for alcohol versus a ban on below cost selling in England 2014: modelling study
por: Brennan, Alan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dam2v93noaaedub06vc81rh27r